AbbVie Inc. is 233.6x more valuable than AGIOS PHARMACEUTICALS, INC. by market capitalization ($399.47 B vs $1.71 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AGIO | ABBV |
|---|---|---|
| Market cap | $1.71 B | $399.47 B |
| US-listed rank | #2223 | #28 |
| Revenue (latest FY) | $54.03M | $61.16B |
| Net income (latest FY) | -$413.00M | $4.23B |
| Net margin | -764.4% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 1,268 | 1,008 |
AbbVie Inc. is 233.6x more valuable than AGIOS PHARMACEUTICALS, INC. by market capitalization ($399.47 B vs $1.71 B).
In their latest fiscal years, AGIOS PHARMACEUTICALS, INC. reported $54.03M in revenue while AbbVie Inc. reported $61.16B.
Full pages: AGIOS PHARMACEUTICALS, INC. and AbbVie Inc., or browse the full rankings.